Trial Profile
An Open Study to Observe OXN Treatment for Patients With Moderate to Severe Non-malignant Pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Oxycodone/naloxone (Primary)
- Indications Pain
- Focus Therapeutic Use
- 20 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jul 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 07 Jun 2011 Planned end date changed from 1 Jun 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.